Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 132-146

  Schoneboom, Bruce A ^a   Catlin, Kristen M K ^a   Marty, Aileen M ^a   Grieder, Franziska B ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Cytokines; Inflammation; Neurodegeneration; Venezuelan equine encephalitis virus (VEE)

Indexed keywords

CYTOKINE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; BRAIN EDEMA; CYTOKINE PRODUCTION; FEMALE; GENE ACTIVATION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ENCEPHALITIS;

ANIMAL; APOPTOSIS; ASTROCYTES; BRAIN EDEMA; CELLS, CULTURED; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GLIOSIS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; NEUROIMMUNOMODULATION; NEURONS; NITRIC-OXIDE SYNTHASE; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR;

EID: 0034703403     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00290-3     Document Type: Article

References (71)

1. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263:1992;C1-C16.
2. Bignami A., Dahl D. Astrocyte-specific protein and neuroglial differentiation. An immunofluorescence study with antibodies to the glial fibrillary acidic protein. J. Comp. Neurol. 153:1974;27-38.
3. Bock E., Moller M., Nissen C., Sensenbrenner M. Glial fibrillary acidic protein in primary astroglial cell cultures derived from newborn rat brain. FEBS Lett. 83:1977;207-211.
4. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
5. Brodie C., Weizman N., Katzoff A., Lustig S., Kobiler D. Astrocyte activation by Sindbis virus: expression of GFAP, cytokines, and adhesion molecules. Glia. 19:1997;275-285.
6. Chao C.C., Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:1994;172-179.
7. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9:1995;355-365.
8. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
9. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
10. Charles, P.C., Trgovcich, J., Davis, N.L., Johnson, R.E., 2000. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. J. Virol., in press.
11. Charles P.C., Walters E., Margolis F., Johnston R.E. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology. 208:1995;662-671.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
13. Chung I.Y., Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144:1990;2999-3007.
14. Davis N.L., Grieder F.B., Smith J.F., Greenwald G.F., Valenski M.L., Sellon D.C., Charles P.C., Johnston R.E. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Arch. Virol. Suppl. 9:1994;99-109.
15. Davis N.L., Powell N., Greenwald G.F., Willis L.V., Johnson B.J., Smith J.F., Johnston R.E. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology. 183:1991;20-31.
16. Davis N.L., Willis L.V., Smith J.F., Johnston R.E. In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology. 171:1989;189-204.
17. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
18. de la Monte S., Castro F., Bonilla N.J., Gaskin de Urdaneta A., Hutchins G.M. The systemic pathology of Venezuelan equine encephalitis virus infection in humans. Am. J. Trop. Med. Hyg. 34:1985;194-202.
19. Eng L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8:1985;203-214.
20. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., Bloom B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:1995;561-572.
21. Garcia-Tamayo J., Carreno G., Esparza J. Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in the rat. J. Pathol. 128:1979;87-91.
22. Grieder F.B., Davis B.K., Zhou X.D., Chen S.J., Finkelman F.D., Gause W.C. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology. 233:1997;302-312.
23. Grieder F.B., Davis N.L., Aronson J.F., Charles P.C., Sellon D.C., Suzuki K., Johnston R.E. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology. 206:1995;994-1006.
24. Grieder F.B., Nguyen H.T. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages. Microb. Pathol. 21:1996;85-95.
25. Grieder F.B., Vogel S.N. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology. 257:1999;106-118.
26. Griffin D.E., Levine B., Ubol S., Hardwick J.M. The effects of alphavirus infection on neurons. Ann. Neurol. 35:1994;S23-S27.
27. Jackson A., Sen Gupta S., Smith J. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet. Pathol. 28:1991;410-418.
28. Jackson A.C., Rossiter J.P. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice. Acta Neuropathol. (Berlin). 93:1997;349-353.
29. Karupiah G., Chen J.H., Mahalingam S., Nathan C.F., MacMicking J.D. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1998;1541-1546.
30. Karupiah G., Chen J.H., Nathan C.F., Mahalingam S., MacMicking J.D. Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J. Virol. 72:1998;7703-7706.
31. Kong L.Y., Wilson B.C., McMillian M.K., Bing G., Hudson P.M., Hong J.S. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell. Immunol. 172:1996;77-83.
32. Kossmann T., Hans V., Imhof H.G., Trentz O., Morganti-Kossmann M.C. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713:1996;143-152.
33. Kreil T.R., Eibl M.M. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology. 219:1996;304-306.
34. Lewis J., Wesselingh S.L., Griffin D.E., Hardwick J.M. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1996;1828-1835.
35. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA. 86:1989;6348-6352.
36. Lowenstein C.J., Hill S.L., Lafond-Walker A., Wu J., Allen G., Landavere M., Rose N.R., Herskowitz A. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1996;1837-1843.
37. MacLean A., Wei X.Q., Huang F.P., Al-Alem U.A., Chan W.L., Liew F.Y. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79:1998;825-830.
38. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Biol. 85:1980;890-902.
39. McIntire F.C., Sievert H.W., Barlow G.H., Finley R.A., Lee A.Y. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry. 6:1967;2363-2372.
40. Mendez E K.T., Clemens K., Haruhiko S., Soldan S.S., Calabresi P., Brady J., Jacobson S. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) tax: induction of tumor necrosis factor alpha and suseptibility to lysis by CD8+ HTLV-1-specific cytotoxic cells. J. Virol. 71:1997;9143-9149.
41. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
42. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
43. MMWR, 1999. MMWR Weekly, CDC, Atlanta, GA, 48, 845-849.
44. MMWR, 1999. Summary of Notifiable Diseases, United States, 1998 MMWR 47, 1-93.
45. MMWR, 1999. Imported Dengue, Florida, 1997-1998 MMWR 48, 1150-1152.
46. Mokhtarian F., Wesselingh S.L., Choi S., Maeda A., Griffin D.E., Sobel R.A., Grob D. Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. J. Neuroimmnol. 66:(1-2):1996;11-12.
47. Morris M.M., Dyson H., Baker D., Harbige L.S., Fazakerley J.K., Amor S. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J. Neuroimmunol. 74:(1-2):1997;185-197.
48. Moore C.G., McLean R.G., Mitchell C.J., Nasci R.S., Tsai T.F., Caliser C.H., Marfin A.A., Moore P.S., Gubler D.J. Guidelines for Arbovirus Surveillance Programs in the United States. 1993;Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Fort Collins, CO.
49. Moreland L.W. Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis. Cleve. Clin. J. Med. 66:1999;367-374.
50. Parra B., Hinton D.R., Lin M.T., Cua D.J., Stohlman S.A. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology. 233:1997;260-270.
51. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Kronke M., Mak T.W. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:1993;457-467.
52. Pulliam L., Moore D., West D.C. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity. J. Neurovirol. 1:1995;219-227.
53. Raff M.C., Fields K.L., Hakomori S.I., Mirsky R., Pruss R.M., Winter J. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res. 174:1979;283-308.
54. Randall R., Mills J.W. Fatal encephalitis in man due to the Venezuelan virus of equine encephalomyelitis in Trinidad. Science. 99:1944;225-226.
55. Rothwell N.J., Strijbos P.J. Cytokines in neurodegeneration and repair. Int. J. Dev. Neurosci. 13:1995;179-185.
56. Ruby J., Horst B., Peschon J.J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:(9):1997;1591-1596.
57. Sauder C., de la Torre J.C. Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection. J. Neuroimmunol. 96:1999;29-45.
58. Scherer W.F., Ellsworth C.A., Ventura A.K. Studies of viral virulence. II. Growth and adsorption curves of virulent and attenuated strains of Venezuelan encephalitis virus in cultured cells. Am. J. Pathol. 62:1971;211-219.
59. Schoneboom B.A., Fultz M.J., Miller T.H., McKinney L.C., Grieder F.B. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. Neurovirol. 5:1999;342-354.
60. Schoneboom B.A., Lee J.S., Grieder F.B. Early expression of IFN-α/β and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. J. Interferon Cytokine Res. 20:(2):2000;205-215.
61. Skaper S.D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64:1995;266-276.
62. Steele K.E., Davis K.J., Stephan K., Kell W., Vogel P., Hart M.K. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Vet. Pathol. 35:1998;386-397.
63. Sun N., Grzybicki D., Castro R.F., Murphy S., Perlman S. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology. 213:1995;482-493.
64. Tolskaya E.A., Romanova L.I., Kolesnikova M.S., Ivannikova T.A., Smirnova E.A., Raikhlin N.T., Agol V.I. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J. Virol. 69:1995;1181-1189.
65. Vaux D.L., Hacker G. Hypothesis: apoptosis caused by cytotoxins represents a defensive response that evolved to combat intracellular pathogens. Clin. Exp. Pharmacol. Physiol. 22:1995;861-863.
66. Vernadakis A. Glia-neuron intercommunications and synaptic plasticity. Prog. Neurobiol. 49:1996;185-214.
67. Vogel P., Abplanalp D., Kell W., Ibrahim M.S., Downs M.B., Pratt W.D., Davis K.J. Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation. Arch. Pathol. Lab. Med. 120:1996;164-172.
68. Wesselingh S.L., Levine B., Fox R.J., Choi S., Griffin D.E. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152:1994;1289-1297.
69. Yoshioka M., Bradley W.G., Shapshak P., Nagano I., Stewart R.V., Xin K.Q., Srivastava A.K., Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv. Neuroimmunol. 5:1995;335-358.
70. Zhao Y., Zhang H., Chiu B., Payne U., Inman R. Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection. Arthritis Rheum. 42:1999;1662-1672.
71. Zheng Y.M., Schafer M.K., Weihe E., Sheng H., Corisdeo S., Fu Z.F., Koprowski H., Dietzschold B. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67:1993;5786-5791.